Clinical trial · Observational
Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa
NCT05414097CI-TRIAL-00076062FINDcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary aim of the study explore drivers of cervical cancer screening and barriers contributing to low screening coverage among women in South Africa. Secondary aims are determining preferences for cervical cancer prevention services using a discrete choice experiment and developing a multi-level package of interventions that will address barriers to cervical cancer screening and improve engagement in care among women.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Development and User Pre-testing Workshops | Other | — | UNRESOLVED |
| Discrete Choice Experiment - Women | Other | — | UNRESOLVED |
| In-depth key stakeholders interviews | Other | — | UNRESOLVED |
| Semi-structured focus group discussions - Women | Other | — | UNRESOLVED |
| semi-structured focus groups discussions - Men | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- label
- Phase 1: 24 Women - FGDs
- description
- Focus groups enrolling HIV-positive, previously screened for cervical cancer; HIV-positive, not previously screened for cervical cancer; HIV-negative, previously screened for cervical cancer; HIV-negative, not previously screened for cervical cancer.
- interventionNames
- Other: Semi-structured focus group discussions - Women
- label
- Phase 1: 16 Men - FGDs
- description
- Focus groups enrolling male partners referred by women previously screened or treated for cervical cancer and by women not previously screened for cervical cancer.
- interventionNames
- Other: semi-structured focus groups discussions - Men
- label
- Phase 1: 12 Key Stakeholders - IDIs
- description
- Stakeholder interviewers with women's groups, women's health providers, laboratory personnel, NGOs, and public health organizations.
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria Focus Groups with HIV-positive Women 1. HIV-positive 2. Women 18 years and older 3. Participants should be willing and able to provide written informed consent Focus Groups with HIV-negative Women 1. HIV-negative 2. Women 18 years and older 3. Participants should be willing and able to provide written informed consent Focus Groups with Men 1. Male partners who are 18 years and older 2. Participants should be willing and able to provide written informed consent In-depth Interviews with Key Stakeholders 1. Healthcare providers working within the public health system and other key stakeholders 2. Individuals 18 years and older 3. Participants should be willing and able to provide written informed consent Exclusion Criteria: Focus Groups with HIV-positive Women 1. Women younger than 18 years 2. Unwilling or unable to provide written informed consent Focus Groups with HIV-negative Women 1. Women younger than 18 years 2. Unwilling or unable to provide written informed consent Focus Groups with Men 1. Male partners younger than 18 years 2. Participants unwilling or unable to provide written informed consent In-depth Interviews with Key Stakeholders 1. Providers who do not work in the public health system 2. Individuals younger than 18 years 3. Participants unwilling or unable to provide written informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.